Vitaros: Canada was a setback, Switzerland was a set back, Germany is a setback. Yet, sales continue to grow and significant markets are in the game. I believe we will see another doubling (at least) in sales again this quarter. The guidance by the company has always been that growth in Europe will be slow. RTD is going to help, hopefully it's on track still. The US will be a better market, but will APRI own 80% or 15% of it with the opt in rights. If I had to apply Vitaros a couple times a week for a few weeks for results, and then (side note) I noticed that it worked even without an application as some users have professed, I would gladly use it. How many of you have asked your friends if they have ever heard of a topical cream treatment for ED? I'm guessing your experience is similar to mine. Nobody has heard about it. I'm guessing many in Europe are still in the blind as well. If you have told your friends about it, how many times have you heard them say they would use it? If your experience is similar to mine, they all have said they would use it or try it. In my experience, none of them have said that the application process would discourage them from using it. Vitaros is still in the very early stages of marketing. It is to early to know how much of the 5 BIL market it will penetrate, imo.
The fellow on the other board has never been right about anything this company does. He was here for Femprox and professed the future of the company hinged on that. He constantly berates Vitaros. The company firmly believes in Vitaros. They would not have gone after the US marketing rights and be developing the RTD, had they not. He's never seen a single financial move coming that the company has made, and he has zero knowledge of how the company plans to address the issue moving forward...yet he spews out gloom and doom theories as if he has unique understanding. He cries a cash raise should have been made a long time ago, as if he understood that at the time the pps was much higher. He understood nothing of the sort. He hasn't seen a single strategic move coming that this company has made. Now he cries Fis will be this companies future and that Denner is here for Fis. Perhaps? But Denner has already lost on his first SERM investment. Perhaps that's why you hedge with APRI, that would make sense. My point? I don't listen to anything he says with any credence.
This company in my view still has a lot of upside.
Happy New Year from Texas! |
